Getting the formula right in growing local biomedical sector

A biotechnologist overseeing the fermentation process, which is key in vaccine manufacturing, at GlaxoSmithKline Biologicals' manufacturing facility in Tuas. PHOTO: GLAXOSMITHKLINE
New: Gift this subscriber-only story to your friends and family

SINGAPORE - Local diagnostics start-up BioCheetah is developing kits to help healthcare professionals quickly identify patients at high risk of having bladder cancer.

Besides a kit that will speed up the diagnosis process in hospitals, it is also looking to roll out a point-of-care test for places that do not have the necessary testing equipment, such as general practitioners' clinics.

Already a subscriber? 

Read the full story and more at $9.90/month

Get exclusive reports and insights with more than 500 subscriber-only articles every month

Unlock these benefits

  • All subscriber-only content on ST app and

  • Easy access any time via ST app on 1 mobile device

  • E-paper with 2-week archive so you won't miss out on content that matters to you

Join ST's Telegram channel and get the latest breaking news delivered to you.